Patent application number | Description | Published |
20080260798 | ALIGNED SCAFFOLDS FOR IMPROVED MYOCARDIAL REGENERATION - The present invention relates to a biocompatible, three-dimensional scaffold useful to grow cells and to regenerate or repair tissue in predetermined orientations. The scaffold is particularly useful for regeneration and repair of cardiac tissue. The scaffold contains layers of alternating A-strips and S-strips, wherein the A-strips within each layer are aligned parallel to each other and preferentially promote cellular attachment over attachment to the S-strips. Methods of producing and implanting the scaffold are also provided. | 10-23-2008 |
20090069789 | METHODS AND DEVICES FOR LOCAL THERAPEUTIC AGENT DELIVERY TO HEART VALVES - Medical devices and methods for delivering a therapeutic agent to a heart valve. | 03-12-2009 |
20090123508 | Implantable Drug Depot for Intrathecal Drug Delivery System for Pain Management - The present disclosure provides an intrathecally-implantable depot having a biodegradable core for extended release of pain-relieving drug into the intrathecal space over at time period of at least a month. The present disclosure further provides methods for preparing a self-contained intrathecally-implantable depot and methods for continuously relieving pain in a subject by implanting an intrathecally-implantable depot having a biodegradable core and releasing a therapeutically-effective amount of analgesic composition from the biodegrading core over a time period of at least one month. | 05-14-2009 |
20090131906 | METHOD, SYSTEM, APPARATUS, AND KIT FOR REMOTE THERAPEUTIC DELIVERY - A therapeutic delivery catheter system method or kit for delivery of therapeutic to a target location is provided. In various embodiments of the present invention the invention may include a catheter with a therapeutic delivery lumen and a therapeutic delivery orifice. The lumen and the orifice may be in fluid communication with each other and may be configured such that therapeutic delivered therethrough may be done at pressures mimicking pressures existing or otherwise normal at the target locations receiving the therapeutic. In some embodiments the catheter may be part of a kit that may include instructions regarding the proper manner of operation of the catheter. These instructions may include suggested target pressures for therapeutic delivery as well as delivery times, and suggested lengths of time for the device to reside at the target area after delivery to allow for proper uptake of the therapeutic. | 05-21-2009 |
20090138074 | DECELLULARIZED EXTRACELLULAR MATRIX OF CONDITIONED BODY TISSUES AND USES THEREOF - The invention is directed to an apparatus, such as a medical device, having a surface coated or covered with a decellularized extracellular matrix or having a component comprising the decellularized extracellular matrix for implantation into a subject, preferably a human. In one embodiment of the invention, a decellularized extracellular matrix is used to form a bodily implant such as a vein, an artery, an esophagus, or a ventricular restraining device. In some embodiments of the invention, the decellularized extracellular matrix is configured to be a time released therapeutic. In another embodiment of the invention, a decellularized extracellular matrix forms an aneurysm treatment device, such as an aneurysm coil, a seal, a pouch, or a filler. In a further embodiment of the invention, decellularized extracellular matrix is used to embolize lesions, tumors, or vessels. Methods for making the tissue regeneration scaffold and methods for manufacturing a coated or covered medical device having a component comprising decellularized extracellular matrix of body tissues are also provided. | 05-28-2009 |
20090157042 | METHODS, DEVICES AND COMPOSITIONS FOR CONTROLLED DRUG DELIVERY TO INJURED MYOCARDIUM - A method for modulating remodeling of an infarct region of a myocardium, the method including the controlled local delivery of therapeutic agent(s) employing microparticles as a carrier, and devices and compositions relating thereto. | 06-18-2009 |
20100092448 | LOCAL CONTROL OF INFLAMMATION - A medical device includes a carrier and an agent. The agent is formulated to control inflammation of biological tissue, such as heart tissue, and is releasably coupled to the carrier. The carrier is configured to be disposed in operative proximity to the biological tissue to be treated by the agent. In one embodiment, the carrier is configured to release the agent or otherwise deliver the agent to the biological tissue, thus controlling inflammation of the tissue. Also, a method to improve healing of biological tissue includes placing a medical device proximate to the heart of a patient, where the medical device has a carrier and an agent configured to control inflammation, the agent is releasably coupled to the carrier. In one embodiment, the method includes causing the agent to be released from the carrier. | 04-15-2010 |
20110130715 | Device and Method for Delivering Micronized Therapeutic Agents in the Body - The present invention provides a catheter and catheter assembly for delivering micronized therapeutic agents to a target site in the body and, in particular, to a target site in the heart. The micronized therapeutic agents are delivered in aerosol form or dry powder form. The present invention also provides a method of delivering micronized therapeutic agents to a target site in the body by placing the therapeutic agents in a catheter, positioning the catheter in the target site, and exposing the therapeutic agents to an energizing mechanism sufficient to create supersonic flow to carry the therapeutic agents from a stationary state in the catheter to a mobile state towards the target site. | 06-02-2011 |
20120010589 | LOCAL DELIVERY OF THERAPEUTIC AGENT TO HEART VALVES - The present invention relates to implantable medical devices and methods that employ these medical devices to treat heart valves. In one embodiment, a medical device is provided comprising a body. The body may have a portion thereof including therapeutic agent and can be configured to support the device proximate a heart valve. Methods in accordance with embodiments of the present invention may also include providing a medical device having a body with at least a portion thereof including a therapeutic agent. These methods may also include positioning the medical device in a location proximate to a downstream surface of the heart valve and securing the device. The therapeutic agent released may then be delivered to the heart valve. | 01-12-2012 |
20120040137 | FIBER COMPOSITE STRUCTURE - Disclosed are fiber composite structures comprising a matrix material and at least one polymeric fiber in contact with the matrix material. The fiber(s) are preferably characterized by a diameter of up to about 20 microns. In certain embodiments, the fiber(s) comprise a therapeutic agent in an amount that exceeds the solubility limit of the therapeutic agent in the fiber polymer. In some embodiments, the fiber(s) comprise an inner radial portion and an outer radial portion. | 02-16-2012 |
20120107439 | IN SITU FORMING HEMOSTATIC FOAM IMPLANTS - Systems and methods related to polymer foams are generally described. Some embodiments relate to compositions and methods for the preparation of polymer foams, and methods for using the polymer foams. The polymer foams can be applied to a body cavity and placed in contact with, for example, tissue, injured tissue, internal organs, etc. In some embodiments, the polymer foams can be formed within a body cavity (i.e., in situ foam formation). In addition, the foamed polymers may be capable of exerting a pressure on an internal surface of a body cavity and preventing or limiting movement of a bodily fluid (e.g., blood, etc.). | 05-03-2012 |
20120265287 | In-Situ Forming Foams for Treatment of Aneurysms - Systems, methods and kits relating to in-situ forming polymer foams for the treatment of aneurysms are disclosed. The systems include an insertable medical device and an in-situ forming foam that is formed from a polymer that reacts in an aqueous environment. When used to treat an aneurysm, the foam is placed into contact with at least a portion of an exterior surface of the medical device and/or the tissue surface of the aneurysm. | 10-18-2012 |
20130071463 | IMPLANTS FOR POSTOPERATIVE PAIN - Medical implants and methods useful in treating postoperative pain are described. The implants comprise one or more electrospun drug-loaded fibers, which fibers comprise a drug useful in the treatment of pain. The implants are implanted at sites of interest including joint capsules, bones, and subcutaneous spaces, and are secured with tissue flaps or fasteners. | 03-21-2013 |
20130092079 | Coated Medical Device and Method for Manufacturing the Same - The medical device of the invention comprises a surface comprising at least one outermost portion and a plurality of depressions. The depressions occupy at least about 80% of the surface area of the surface. The depressions contain a coating material that preferably comprises a biologically active material and/or polymer, and the outermost portion is substantially free of any coating material. The invention is also directed to a method for manufacturing a medical device. The method comprises applying a coating material to the surface of the medical device by using at least one roller. | 04-18-2013 |
20130110066 | Foam and Delivery System for Treatment of Postpartum Hemorrhage | 05-02-2013 |
20130317418 | In-situ Forming foams with outer layer - Systems, methods and kits relating to in-situ forming polymer foams for the treatment of aneurysms or fluid filled spaces are disclosed. The systems include an insertable medical device and an in-situ forming foam of lava like materials with a fast forming outer skin and a slower hardening interior that is formed from a one-, two- or multi-part formulation. When used to treat an aneurysm, the foam is placed into contact with at least a portion of an exterior surface of the medical device and/or the tissue surface of the aneurysm. | 11-28-2013 |
20140322512 | CORE-SHEATH FIBERS AND METHODS OF MAKING AND USING SAME - According to one aspect of the invention, multicomponent fiber are provided, which comprise (a) a polymeric core that comprises a core-forming polymer and (b) a polymeric sheath that comprises a sheath-forming polymer that is different than the core-forming polymer. Examples of core-forming polymers include, for instance, crosslinked polysiloxanes and thermoplastic polymers, among others. Examples of sheath-forming polymers include, for instance, solvent-soluble polymers, degradable polymers and hydrogel-forming polymers, among others. Other aspects of the present invention pertain to methods of forming such multicomponent fibers. For example, in certain preferred embodiments, the multicomponent fibers are formed using coaxial electrospinning techniques. Still other aspects of the present invention pertain to meshes and other articles that are formed using the multicomponent fibers. | 10-30-2014 |